Predicting outcomes in atrial fibrillation and heart failure
Part of Heart & circulation clinical trials.
This study looks at patients who have both atrial fibrillation (irregular heartbeats) and heart failure. It aims to predict health outcomes for people who are having a procedure called ablation, which aims to restore a normal heart rhythm. Participating could help doctors understand who might benefit most from this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have persistent atrial fibrillation (a type of irregular heartbeat that lasts more than a week).
- Your heart's pumping ability is reduced (ejection fraction of 40% or less).
- You have heart failure symptoms like shortness of breath or fatigue.
- You are taking standard heart failure medications and plan to have a procedure called ablation to treat your irregular heartbeat.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a procedure called catheter ablation, which treats irregular heartbeats in atrial fibrillation, can improve outcomes in people who also have heart failure with mildly reduced or preserved pumping function. The procedure aims to restore a normal heart rhythm and may help reduce symptoms.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This study tests whether a catheter ablation procedure can help people with atrial fibrillation and a kind of heart failure where the heart pumps normally but doesn't relax properly (HFpEF). It looks at whether the procedure can improve symptoms and heart function.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study compares two treatments for people with atrial fibrillation and heart failure: one is a procedure to fix the irregular heartbeat (AF ablation), and the other involves a different type of pacing for the heart. It aims to find which approach helps you feel better and stay out of the hospital.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.